$TALK
Talkspace, Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024094085 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $47.40M $46.06M
YoY Change 22.65% 29.21%
Cost Of Revenue $25.78M $25.11M
YoY Change 30.21% 40.79%
Gross Profit $21.62M $20.95M
YoY Change 14.71% 17.62%
Gross Profit Margin 45.61% 45.49%
Selling, General & Admin $17.49M $20.61M
YoY Change -5.15% 12.19%
% of Gross Profit 80.91% 98.39%
Research & Development $2.352M $2.163M
YoY Change -43.73% -48.14%
% of Gross Profit 10.88% 10.32%
Depreciation & Amortization $231.0K $220.0K
YoY Change -23.0% -27.15%
% of Gross Profit 1.07% 1.05%
Operating Expenses $21.52M $24.44M
YoY Change -10.43% 0.9%
Operating Profit $99.00K -$3.486M
YoY Change -98.09% -154.4%
Interest Expense $1.701M $3.044M
YoY Change 118.08% 77.8%
% of Operating Profit 1718.18%
Other Income/Expense, Net
YoY Change
Pretax Income $1.800M -$442.0K
YoY Change -59.09% -109.41%
Income Tax -$74.00K $32.00K
% Of Pretax Income -4.11%
Net Earnings $1.874M -$474.0K
YoY Change -142.46% -89.92%
Net Earnings / Revenue 3.95% -1.03%
Basic Earnings Per Share $0.01 $0.00
Diluted Earnings Per Share $0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 168.2M 169.7M
Diluted Shares Outstanding 173.8M 169.1M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.0M $114.9M
YoY Change -5.03% -8.87%
Cash & Equivalents $119.0M $114.9M
Short-Term Investments
Other Short-Term Assets $2.922M $2.302M
YoY Change -33.79% -21.16%
Inventory
Prepaid Expenses
Receivables $9.602M $11.55M
Other Receivables $0.00 $0.00
Total Short-Term Assets $131.5M $128.8M
YoY Change -4.5% -6.31%
LONG-TERM ASSETS
Property, Plant & Equipment $4.329M $2.544M
YoY Change 1491.54% 457.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.713M $5.021M
YoY Change 1630.15% 982.11%
Total Long-Term Assets $6.713M $5.021M
YoY Change 155.15% 63.18%
TOTAL ASSETS
Total Short-Term Assets $131.5M $128.8M
Total Long-Term Assets $6.713M $5.021M
Total Assets $138.2M $133.8M
YoY Change -1.51% -4.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.299M $7.733M
YoY Change 27.44% 41.01%
Accrued Expenses $6.282M $5.664M
YoY Change -17.34% -45.77%
Deferred Revenue $3.507M $2.733M
YoY Change -3.18% -25.79%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.05M $17.78M
YoY Change -8.62% -9.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $542.0K $635.0K
YoY Change 185.26% 115.25%
Total Long-Term Liabilities $542.0K $635.0K
YoY Change 185.26% 115.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.05M $17.78M
Total Long-Term Liabilities $542.0K $635.0K
Total Liabilities $20.64M $19.75M
YoY Change -8.77% -4.73%
SHAREHOLDERS EQUITY
Retained Earnings -$270.5M -$272.3M
YoY Change 0.51% 2.89%
Common Stock $17.00K $16.00K
YoY Change 6.25% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $117.6M $114.0M
YoY Change
Total Liabilities & Shareholders Equity $138.2M $133.8M
YoY Change -1.51% -4.79%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $1.874M -$474.0K
YoY Change -142.46% -89.92%
Depreciation, Depletion And Amortization $231.0K $220.0K
YoY Change -23.0% -27.15%
Cash From Operating Activities $6.205M $4.809M
YoY Change -659.01% 1564.01%
INVESTING ACTIVITIES
Capital Expenditures $1.687M $1.765M
YoY Change 16770.0% 176400.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$1.687M -$1.765M
YoY Change 5523.33% 176400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -437.0K -8.409M
YoY Change -218.11% -1247.2%
NET CHANGE
Cash From Operating Activities 6.205M 4.809M
Cash From Investing Activities -1.687M -1.765M
Cash From Financing Activities -437.0K -8.409M
Net Change In Cash 4.081M -5.365M
YoY Change -630.0% -625.47%
FREE CASH FLOW
Cash From Operating Activities $6.205M $4.809M
Capital Expenditures $1.687M $1.765M
Free Cash Flow $4.518M $3.044M
YoY Change -503.39% 956.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the condensed consolidated financial statements. The Company’s significant estimates and assumptions used in these condensed consolidated financial statements include, but are not limited to, the recognition and disclosure of revenue recognition, stock-based compensation awards and the fair value of warrant liabilities. The Company bases its estimates on historical factors, current circumstances and the experience and judgment of management. The Company evaluates its assumptions on an ongoing basis. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based on information available at the time they are made. Estimates, by their nature, are based on judgment and available information, therefore, actual results could be materially different from these estimates.</span></p>
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46058000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35645000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91474000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68981000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3572000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1202000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1028000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
888000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2544000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
314000
us-gaap Legal Fees
LegalFees
0
dei Entity Central Index Key
EntityCentralIndexKey
0001803901
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39314
dei Entity Registrant Name
EntityRegistrantName
TALKSPACE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4636604
dei Entity Address Address Line1
EntityAddressAddressLine1
622 Third Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
284-7206
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
168212240
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114913000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123908000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11554000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10174000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2302000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5718000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
128769000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
139800000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5021000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3107000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2129000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5359000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2421000
CY2024Q2 us-gaap Assets
Assets
133790000
CY2023Q4 us-gaap Assets
Assets
142221000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7733000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6111000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2733000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3069000
CY2024Q2 talk Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
7313000
CY2023Q4 talk Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
12468000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17779000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21648000
CY2024Q2 talk Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
1332000
CY2023Q4 talk Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
1842000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
635000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
85000
CY2024Q2 us-gaap Liabilities
Liabilities
19746000
CY2023Q4 us-gaap Liabilities
Liabilities
23575000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168169158
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168169158
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168428856
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168428856
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
16000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
16000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
386352000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
389014000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-272324000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270384000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
114044000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
118646000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133790000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
142221000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46058000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35645000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91474000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68981000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
25107000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
17833000
us-gaap Cost Of Revenue
CostOfRevenue
48792000
us-gaap Cost Of Revenue
CostOfRevenue
34421000
CY2024Q2 us-gaap Gross Profit
GrossProfit
20951000
CY2023Q2 us-gaap Gross Profit
GrossProfit
17812000
us-gaap Gross Profit
GrossProfit
42682000
us-gaap Gross Profit
GrossProfit
34560000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2163000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4171000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5902000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9524000
CY2024Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1661000
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1675000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3125000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3276000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13269000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13045000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26278000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26514000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7344000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5329000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12542000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10693000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
24437000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
24220000
us-gaap Operating Expenses
OperatingExpenses
47847000
us-gaap Operating Expenses
OperatingExpenses
50007000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3486000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6408000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5165000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15447000
CY2024Q2 talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-3044000
CY2023Q2 talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-1712000
talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-3422000
talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-2136000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-442000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4696000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1743000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13311000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
197000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
151000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-474000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4704000
us-gaap Net Income Loss
NetIncomeLoss
-1940000
us-gaap Net Income Loss
NetIncomeLoss
-13462000
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4432000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-474000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4704000
us-gaap Net Income Loss
NetIncomeLoss
-1940000
us-gaap Net Income Loss
NetIncomeLoss
-13462000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.08
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169148522
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
169148522
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164195697
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164195697
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168997734
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168997734
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163003363
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163003363
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
118646000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
741000
CY2024Q1 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-595000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2252000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1466000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
119578000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
843000
CY2024Q2 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-1248000
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
8004000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3349000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-474000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
114044000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
127536000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
621000
CY2023Q1 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-65000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2303000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8758000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
121637000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
869000
CY2023Q2 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-136000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2129000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4704000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
119795000
us-gaap Net Income Loss
NetIncomeLoss
-1940000
us-gaap Net Income Loss
NetIncomeLoss
-13462000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
421000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
608000
us-gaap Share Based Compensation
ShareBasedCompensation
5359000
us-gaap Share Based Compensation
ShareBasedCompensation
4432000
talk Remeasurement Of Warrant Liabilities
RemeasurementOfWarrantLiabilities
510000
talk Remeasurement Of Warrant Liabilities
RemeasurementOfWarrantLiabilities
119000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1380000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1220000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-3416000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1452000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1622000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-977000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
336000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
672000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5155000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6058000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-79000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-172000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1418000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13748000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2110000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-28000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2150000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1584000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1490000
talk Payments For Employee Taxes Withheld Related To Restricted Stock Units Vested
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
1843000
talk Payments For Employee Taxes Withheld Related To Restricted Stock Units Vested
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
201000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8004000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8263000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1289000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8995000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12441000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123908000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138545000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114913000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126104000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
33000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
176000
talk Non Cash Investing Lease Liabilities Arising From Obtaining Right Of Use Assets
NonCashInvestingLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
595000
talk Non Cash Investing Lease Liabilities Arising From Obtaining Right Of Use Assets
NonCashInvestingLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
0
talk Non Cash Compensation Capitalized As Part Of Capitalization Of Internal Use Software Costs
NonCashCompensationCapitalizedAsPartOfCapitalizationOfInternalUseSoftwareCosts
242000
talk Non Cash Compensation Capitalized As Part Of Capitalization Of Internal Use Software Costs
NonCashCompensationCapitalizedAsPartOfCapitalizationOfInternalUseSoftwareCosts
0
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169148522
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
169148522
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164195697
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164195697
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168997734
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168997734
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163003363
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163003363
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q2 talk Accrued Employee Compensation
AccruedEmployeeCompensation
3358000
CY2023Q4 talk Accrued Employee Compensation
AccruedEmployeeCompensation
7269000
CY2024Q2 talk Accrued Severance
AccruedSeverance
978000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
680000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
626000
CY2024Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
648000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1525000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1649000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3048000
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7313000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12468000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 talk Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q2 talk Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-094085-index-headers.html Edgar Link pending
0000950170-24-094085-index.html Edgar Link pending
0000950170-24-094085.txt Edgar Link pending
0000950170-24-094085-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img209283681_0.jpg Edgar Link pending
img209283681_1.jpg Edgar Link pending
img209283681_2.jpg Edgar Link pending
img209283681_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
talk-20240630.htm Edgar Link pending
talk-20240630.xsd Edgar Link pending
talk-ex10_24.htm Edgar Link pending
talk-ex31_1.htm Edgar Link pending
talk-ex31_2.htm Edgar Link pending
talk-ex32_1.htm Edgar Link pending
talk-ex32_2.htm Edgar Link pending
talk-20240630_htm.xml Edgar Link completed